NNN

NLS Pharmaceutics Ltd.

No trades
See on Supercharts

NLSP fundamentals

An in-depth look to NLS Pharmaceutics Ltd. operating, investing, and financing activities

NLSP free cash flow for H1 24 is -1.53 M USD. For 2023, NLSP free cash flow was -9.68 M USD and operating cash flow was -9.68 M USD.

‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
TTM
Free cash flowYoY growth